← Home
Medtronic
-13.67%
Healthcare & biotech / Medical devices and services
🧩 Revenue Segmentation by Product
Switch to Location
| Fiscal year | Segment | Value |
|---|---|---|
| 2024 | Diabetes Group | 2.49B |
| 2024 | Neuroscience Group | 9.41B |
| 2024 | Medical Surgical | 8.42B |
| 2024 | Cardiac and Vascular Group | 11.83B |
| 2023 | Cardiac and Vascular Group | 11.57B |
| 2023 | Diabetes Group | 2.26B |
| 2023 | Neuroscience Group | 8.96B |
| 2023 | Medical Surgical | 8.43B |
| 2022 | Cardiac and Vascular Group | 11.42B |
💰 Explore more revenue segmentation data for Medtronic!
Sign up for free or log in📚 Your free copy of "The Checklist Value Investor — A Smarter Way to Pick Stocks" is waiting